prognosticheck® value proposition strategy and focus

Upload: ipgdx

Post on 30-May-2018

218 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    1/31

    2005 IPGDx, LLC

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    2/31

    PROGNOSTICHECK

    Value Proposition:

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    3/31

    STRATEGY & FOCUS

    Reliable

    base healthcare

    decisions upon

    Scientific Excellent Com assionate

    knowledgebase

    training &support

    caringcommunication

    Patient, Physician,

    Manufacturer

    multi-media formats

    Pre-Learning

    Assessment

    2005 IPGDx, LLC

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    4/31

    INDIVIDUALLY TARGETED CURRICULUM

    Patients and Families

    Physicians

    Other healthcare rovidersNurses

    ac es Phase of care

    Manufacturers armaceu ca s er n erven ons

    Prescription

    2005 IPGDx, LLC

    Nonprescription

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    5/31

    THREE FRONTS OF CHANGE

    Therapeutic efficacy Healthcare delivery system

    Ethical and cultural expectations

    Duties and responsibilities within a new

    2005 IPGDx, LLC

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    6/31

    CHRONIC DISEASE

    Diagnosis established

    Tx limited/repetitive

    Complications

    Anticipation Avoidance

    Mitigation

    Scope of deterioration

    2005 IPGDx, LLC

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    7/31

    CHARACTER OF CHRONIC ILLNESS

    Occurs with substantial reserve capacity Progressively long natural course

    Serious then fatal

    Progressively worsening

    Frailty/prolonged dwindling (Cliff Edge) Little available reserves

    Small u set cascades

    2005 IPGDx, LLC

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    8/31

    Hospitalizations

    Severit of disease

    Present on admission

    Overstaying DRG LOS

    Complications

    SIRS

    2005 IPGDx, LLC

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    9/31

    From:

    Living Well at the End of

    Life;

    Lynn & Adamson

    2003 Rand Health

    2005 IPGDx, LLC

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    10/31

    ~20%

    ~

    ~

    2005 IPGDx, LLC *~20% other and/or undefined

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    11/31

    2005 IPGDx, LLC

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    12/31

    Of the ~2.5M annual deathsless than fort ercent died

    under hospice care

    2005 IPGDx, LLC

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    13/31

    THOSE WITH CHRONIC DISEASE

    2005 IPGDx, LLC

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    14/31

    CHANGES IN HEALTHCARE DELIVERY

    < economic independence < professional autonomy

    > external review

    > administrative oversight

    Optimize outcome while minimizing costs Proffer decisions with weighted

    administrative and clinical consequences

    2005 IPGDx, LLC

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    15/31

    CHANGES IN HEALTHCARE DELIVERY

    Resource Allocation

    > cost

    To produce > benefit Com arative metric/risk ad ustments

    Relative levels of illness and treatment ys em compar sons

    2005 IPGDx, LLC

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    16/31

    CHANGES IN HEALTHCARE DELIVERY

    D m n r d Eff i n

    Assessment of the probability of

    Assumption of therapeutic efficacy

    n erme a e en po n s pre c ve olong-term outcomes

    re ct ve n ngs

    Pre-symptomatic occult illnessPredicting consequences

    Benefit of advanced interventions

    2005 IPGDx, LLC

    Adherence metrics

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    17/31

    2005 IPGDx, LLC

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    18/31

    ETHICAL DECISION MAKING

    ommun cat on requ re

    Consumerism Informed consent

    Risk (cost) / Benefit

    Availability Allocation

    2005 IPGDx, LLC

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    19/31

    2005 IPGDx, LLC

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    20/31

    END OF LIFE COSTS

    2005 IPGDx, LLC

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    21/31

    CULTURAL EXPECTATIONS

    Outcome inevitability Likelihood of recovery

    Justice

    Beneficence

    conomy

    2005 IPGDx, LLC

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    22/31

    END OF LIFE CARE

    Good Death v BAD

    ontro - om ort- ommun cat on

    Discussed with family

    Planned for

    Management of

    ome care

    Physical-Spiritual-Emotional-Social-Cost

    2005 IPGDx, LLC

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    23/31

    2005 IPGDx, LLC

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    24/31

    2005 IPGDx, LLC

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    25/31

    2005 IPGDx, LLC

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    26/31

    2005 IPGDx, LLC

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    27/31

    2005 IPGDx, LLC

    PROGNOSTICHECK

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    28/31

    PROGNOSTICHECK

    If Sick How Sick

    Characterization of disease

    Presence-Severity-Progression Effectiveness of thera ies

    Optimized individual response

    -

    Palliative care and Hospice

    2005 IPGDx, LLC

    TARGETED MARKET SEGMENTS

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    29/31

    TARGETED MARKET SEGMENTS

    Innovators First 5% - 10% that adopt the productEarly Adopters Next 10% - 15%

    Early Majority Next 30%

    Late Majority Next 30%

    La ards Remainin 20%

    CHARACTERISTICS:

    something new and different

    Social integration: frequent and extensive contact with others in

    ones area

    Cosmopolitan: point of view extending beyond the immediate

    Social mobility: upward movement on the social scale

    2005 IPGDx, LLC

    something new)

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    30/31

    2005 IPGDx, LLC

  • 8/14/2019 PrognostiCheck Value Proposition Strategy and Focus.

    31/31

    2005 IPGDx, LLC